sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-Aug-2016 18:13
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1295.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 29-Jul-2016
Cell Reports
Zika infection is caused by one virus serotype, NIH study finds
Vaccination against a single strain of Zika virus should be sufficient to protect against genetically diverse strains of the virus, according to a study conducted by investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health; Washington University in St. Louis; and Emory University in Atlanta.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 29-Jul-2016
Science Immunology
Tracking how HIV disrupts immune system informs vaccine development
One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can't seem to induce the same response.
NIH/National Institute of Allergy and Infectious Diseases, Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery, MRC Programme Grant

Contact: Samiha Khanna
samiha.khanna@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 28-Jul-2016
PLOS Pathogens
INRS professor's team unveils new Leishmania virulence strategies
Professor Albert Descoteaux of INRS-Institut Armand-Frappier Research Centre and his team have discovered novel virulence strategies employed by the Leishmania parasite. These scientific breakthroughs recently published in the prestigious PLOS Pathogens journal represent two important clues to understanding the cellular and molecular mechanisms governing the parasitic infections that cause leishmaniasis, a neglected tropical disease endemic in one hundred countries.
Canadian Institutes of Health Research, Medical Research Council, Centre for Host-Parasite Interactions

Contact: Gisèle Bolduc
gisele.bolduc@adm.inrs.ca
418-654-2501
Institut national de la recherche scientifique - INRS

Public Release: 28-Jul-2016
Thorax
Introduction of screening could significantly reduce lung cancer deaths
The introduction of lung cancer screening in the UK could significantly reduce deaths in high risk groups, without causing participants the undue stress sometimes associated with medical tests.

Contact: Julia Short
ShortJ4@cardiff.ac.uk
44-029-208-75596
Cardiff University

Public Release: 28-Jul-2016
PLOS Pathogens
Open-source drug discovery a success
In what is being called the first-ever test of open-source drug-discovery, researchers from around the world have successfully identified compounds to pursue in treating and preventing parasite-borne illnesses such as malaria as well as cancer. The results have ignited more a dozen drug-development projects for a variety of diseases.
Medicines for Malaria Venture

Contact: Bobbi Nodell
bnodell@uw.edu
206-543-7129
University of Washington Health Sciences/UW Medicine

Public Release: 28-Jul-2016
PLOS Pathogens
Toward an effective TB vaccine: Analysis of the immune response to a promising candidate
BCG, the only currently approved TB vaccine, is only partially effective. Given the complicated TB treatment, the rise of adult TB cases in conjunction with the HIV epidemic, and increasing multidrug-resistant TB strains, a new and better vaccine is a global health priority. A study published on July 28 in PLOS Pathogens dissects the immune response in mice to an experimental vaccine and shows why it is highly effective.

Contact: Laleh Majlessi
laleh.majlessi@pasteur.fr
PLOS

Public Release: 27-Jul-2016
Neuropsychiatric Disease and Treatment
Zika virus challenges for neuropsychiatry recently published by Dove Medical Press
The Zika virus led the World Health Organization to declare the outbreak a global public health emergency in February 2016, but how much is really known about its neurobiology and potential neuropsychiatric manifestations?

Contact: Angela Jones
angela@dovepress.com
Dove Medical Press

Public Release: 27-Jul-2016
Cell
Studies in mice provide insights into antibody-Zika virus interactions
In research that could inform prophylactic treatment approaches for pregnant women at risk of Zika virus infection, investigators conducted experiments in mice and identified six Zika virus antibodies, including four that neutralize African, Asian and American strains of the mosquito-borne virus. The NIAID-supported team also developed atomic-level X-ray crystal structure images showing four of the antibodies in complex with three distinct regions (epitopes) of a key Zika protein.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 27-Jul-2016
The Lancet
Physical inactivity cost the world $67 billion in 2013 says first ever estimate
A world-first study has revealed that in 2013, physical inactivity cost $67.5 billion globally in health-care expenditure and lost productivity, revealing the enormous economic burden of an increasingly sedentary world. The study, published today in The Lancet, was led by Dr. Melody Ding from University of Sydney, leader of the current Lancet physical activity series.

Contact: Kobi Print
kobi.print@sydney.edu.au
61-481-012-729
University of Sydney

Public Release: 26-Jul-2016
Vector-Borne and Zoonotic Diseases
Could the deadly mosquito-borne yellow fever virus cause a Zika-like epidemic in the Americas?
Yellow fever virus (YFV), a close relative of Zika virus and transmitted by the same type of mosquito, is the cause of an often-fatal viral hemorrhagic fever and could spread via air travel from endemic areas in Africa to cause international epidemics.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 26-Jul-2016
Protein & Cell
Cracking the mystery of Zika virus replication
Zika virus has become a household word. It can cause microcephaly, a birth defect where a baby's head is smaller than usual. Additionally, it is associated with Guillain-Barré syndrome, a neurological disorder that could lead to paralysis and even death. However, how this microbe replicates in the infected cells remains a mystery. Now, an international team has unraveled the puzzle of how Zika virus replicates and published their finding in Springer's journal Protein & Cell.
National Basic Research Program of China, National Natural Science Foundation of China

Contact: June Tang
june.tang@springer.com
86-108-267-0211
Springer

Public Release: 26-Jul-2016
European Journal of Preventive Cardiology
Low physical capacity second only to smoking as highest death risk
A 45 year study in middle-aged men has shown that the impact of low physical capacity on risk of death is second only to smoking. The research is published today in the European Journal of Preventive Cardiology.
Förenade Liv

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 25-Jul-2016
Best-selling lipid for skin and hair also holds promise for Alzheimer's
The best-selling lipid in the world, often prominently featured on skin cream and shampoo labels, appears to also hold promise for Alzheimer's treatment, scientists say.
National Institutes of Health

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 25-Jul-2016
Journal of Allergy and Clinical Immunology
Hot desert storms increase risk of bacterial meningitis in Africa
Exposure to airborne dust and high temperatures are significant risk factors for bacterial meningitis, a new study by the University of Liverpool has found.

Contact: Nicola Frost
nicola.frost@liverpool.ac.uk
University of Liverpool

Public Release: 25-Jul-2016
Nature Structural & Molecular Biology
Researchers 'solve' key Zika virus protein structure
Researchers have revealed the molecular structure of a protein produced by the Zika virus that is thought to be involved in the virus's reproduction and its interaction with a host's immune system.

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 25-Jul-2016
Annals of Internal Medicine
Low Zika risk for travelers to Olympics in Brazil, study finds
The Zika virus poses a negligible health threat to the international community during the summer Olympic Games that begin next month in Rio de Janeiro, Brazil, according to researchers at Yale School of Public Health.

Contact: Michael Greenwood
michael.greenwood@yale.edu
203-737-5151
Yale University

Public Release: 25-Jul-2016
Nature Genetics
Newly found, 'thrifty' genetic variant influences Samoan obesity
A new study reports that a genetic variant that affects energy metabolism and fat storage partly explains why Samoans have among the world's highest levels of obesity.
National Institutes of Health, Brown University

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 24-Jul-2016
PLOS Pathogens
ANU scientists exploit malaria's Achilles' heel
Malaria researchers at the Australian National University have found one of the malaria parasite's best weapons against drug treatments turns out to be an Achilles' heel, which could be exploited to cure the deadly disease.
National Health and Medical Research Council

Contact: Dr. Rowena Martin
rowena.martin@anu.edu.au
61-261-970-051
Australian National University

Public Release: 21-Jul-2016
Royal Society Interface
Three-drug combinations could help counter antibiotic resistance, UCLA biologists report
Bacteria resistance to antibiotics can be offset by combining three antibiotics that interact well together, even when none of the individual three, nor pairs among them, might be very effective in fighting harmful bacteria, UCLA life scientists report in the journal Royal Society Interface -- an important advance because approximately 700,000 people each year die from drug-resistant infections.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 21-Jul-2016
American Journal of Physical Anthropology
For whom the births (and worms) toll
Studies of Bolivian forager-farmers by UCSB researchers shed light on costs of high birthrates, effects of pathogens on metabolism

Contact: Jim Logan
jim.logan@ucsb.edu
805-893-3071
University of California - Santa Barbara

Public Release: 21-Jul-2016
Journal of Infectious Diseases
UTMB researchers find first direct evidence that A. aegypti mosquito transmits Zika virus
In collaboration with colleagues from Mexico, University of Texas Medical Branch at Galveston researchers were the first to directly connect the Aedes aegypti mosquito with Zika transmission in the Americas, during an outbreak in southern Mexico. The findings are available in the Journal of Infectious Diseases. The findings will help scientists to better target efforts for controlling the population of mosquitoes carrying the Zika virus.
National Institutes of Health

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 21-Jul-2016
PLOS Neglected Tropical Diseases
Stop the snails
A study published in PLOS NTDs reports that successful Schistosomiasis control programs over the past century relied, at least in part, on reducing the freshwater snails that are an essential host in the parasite life cycle.
Woods Institute's Environmental Ventures Projects at Stanford University, Stanford Institute for Innovation in Developing Economies

Contact: Susanne Sokolow
ssokolow@stanford.edu
831-247-4271
PLOS

Public Release: 21-Jul-2016
PLOS Pathogens
Fluorescent trypanosomes reveal invasion of skin and beyond following tsetse fly bites
Trypanosome parasites cause sleeping sickness in Africa. If left untreated, the infection causes coma and eventually death. A study published on July 21 in PLOS Pathogens takes a close look at what happens after an infected tsetse fly transmits parasites into the skin of a mouse host and shows that very few parasites are needed to successfully colonize the host. In addition, multiplication of parasites at the bite site creates a reservoir from which parasites can be picked up by subsequent tsetse fly bites.

Contact: Jan Van Den Abbeele
jvdabbeele@itg.be
PLOS

Public Release: 20-Jul-2016
BMC Medicine
Improving health facility efficiency could markedly expand HIV treatment
Health facilities in Kenya, Uganda, and Zambia could extend life-sustaining antiretroviral therapy to hundreds of thousands of people living with HIV if facilities improved the efficiency of service delivery. This is one of the main findings from a paper published today in BMC Medicine, co-authored by the Institute for Health Metrics and Evaluation and collaborators from Action Africa Help-International in Kenya, the Infectious Diseases Research Collaboration in Uganda, and the University of Zambia in Zambia.
Disease Control Priorities Network

Contact: Kayla Albrecht
kaylaalbrecht@gmail.com
206-897-3792
Institute for Health Metrics and Evaluation

Public Release: 20-Jul-2016
Journal of Acquired Immune Deficiency Syndromes
Preventing HIV in transgender people -- JAIDS assembles critical evidence
Programs to reduce the high risk of HIV infection among transgender people are urgently needed--but efforts are hindered by a lack of accurate information on HIV prevalence, HIV incidence, and specific risk factors facing this key population. A special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes presents essential information to meet the challenges of HIV prevention in the transgender population. The journal is published by Wolters Kluwer.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Showing releases 51-75 out of 1295.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>